High-throughput method for the analysis of venlafaxine in pharmaceutical formulations and biological fluids, using a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate chemiluminescence system in a two-chip device

Haider A J Al Lawati*, Gouri B. Varma, Fakhr Eldin O Suliman

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

A simple, rapid and sensitive chemiluminescent (CL) method for the assay of venlafaxine (VEN) in pharmaceutical formulations and serum samples by a two-chip device is proposed. The method is based on the reaction of this drug with a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate CL system. The optimum chemical conditions for CL emission were investigated. The calibration graph was linear for the concentration range 0.02-8.0 μg/mL. The detection and quantification limits were found to be 0.006 and 0.018 μg/mL, respectively, while the relative standard deviation (RSD) was

Original languageEnglish
Pages (from-to)44-49
Number of pages6
JournalLuminescence
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2013

Keywords

  • chemiluminescence
  • microfluidics
  • Tris(2,2′-bipyridyl) ruthenium(II)
  • two-chip device
  • venlafaxine

ASJC Scopus subject areas

  • Biophysics
  • Chemistry (miscellaneous)
  • Medicine(all)

Access to Document

Fingerprint Dive into the research topics of 'High-throughput method for the analysis of venlafaxine in pharmaceutical formulations and biological fluids, using a tris(2,2′-bipyridyl) ruthenium(II)-peroxydisulphate chemiluminescence system in a two-chip device'. Together they form a unique fingerprint.

Cite this